Vancouver, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Emergen research is one of the pioneers in providing strategic insights for emerging and disruptive technologies which are supposed to show exponential growth in the near future., has released a report that delves deep into the dynamic landscape of the infertility treatment market. The field of Infertility Treatment has seen significant advancements and increased attention in recent years, as the prevalence of infertility issues has become a global concern. With growing awareness and the desire for parenthood, the Infertility Treatment market has expanded, offering a range of innovative solutions to address this pressing issue. The utilization of cutting-edge medical technologies and data-driven insights is transforming the landscape of infertility care, providing hope and possibilities for individuals and couples struggling with fertility challenges.
Infertility treatment refers to the medical interventions, procedures, and therapies designed to address and overcome difficulties in achieving pregnancy for individuals or couples who are unable to conceive naturally. Infertility is typically diagnosed when a couple has been actively trying to conceive for a specified period without success, usually for a year or more of regular unprotected intercourse.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1841
According to the most recent analysis by Emergen Research, the global market for infertility treatments was valued at USD 1.53 billion in 2021 and is predicted to grow steadily at a rate of 8.1% during the projected period. Major drivers influencing market revenue growth include the expansion of fertility clinics on a global scale, the decline in fertility rates, technological improvements, an increase in medical tourism due to affordable treatment alternatives, and the usage of reproductive treatment options by single parents and same-sex couples.
Scope of Research
| Report Details | Outcome |
| Market Size in 2021 | USD 1.53 Billion |
| CAGR (2022–2030) | 8.1% |
| Revenue Forecast to 2030 | USD 3.10 Billion |
| Base Year for Estimation | 2021 |
| Historical Data | 2019–2020 |
| Forecast Period | 2022–2030 |
| Quantitative Units | Revenue in USD Billion and CAGR in % from 2022 to 2030 |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered | Product, procedure, patient type, end-use and region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Country Scope | U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa |
| Key Companies Profiled | Ferring B.V., Merck & Co., Inc., Bayer AG, Abbott, Sumitomo Pharma Co., Ltd., Livzon, Zydus Group, Oxolife, Bio-Rad Laboratories, Inc., Mankind Pharma |
| Customization Scope | 10 hours of free customization and expert consultation |
Major Companies and Competitive Landscape
The global infertility treatment market is fairly fragmented, with a number of large and medium-sized players accounting for majority market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective solutions. Some major companies included in the global infertility treatment market report are:
- Ferring B.V.
- Merck & Co., Inc.
- Bayer AG
- Abbott
- Sumitomo Pharma Co., Ltd.
- Livzon
- Zydus Group
- Oxolife
- Bio-Rad Laboratories, Inc.
- Mankind Pharma
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1841
Strategic Development
On 15th July 2023, FertiliCare Innovations, a trailblazer in the field of reproductive healthcare, introduced a transformative advancement in the Infertility Treatment market – FertiGenix. This groundbreaking solution is set to reshape the landscape of infertility care, catering to the diverse challenges faced by individuals and couples seeking to overcome fertility obstacles.
FertiGenix is a comprehensive and cutting-edge platform designed to address the multifaceted aspects of infertility treatment. It goes beyond conventional approaches, offering a range of innovative features that elevate the effectiveness, personalization, and overall experience of infertility care. This solution is tailored to meet the unique needs of patients while leveraging the latest advancements in reproductive medicine.
What Drives the Infertility Treatment Market?
The global prevalence of infertility has been on the rise due to factors such as delayed parenthood, lifestyle changes, environmental influences, and underlying health conditions. As more individuals and couples face fertility issues, the demand for infertility treatment options grows.
The trend of couples delaying parenthood for career or personal reasons has led to a higher proportion of individuals seeking fertility treatment as they age. Advanced maternal and paternal age is associated with increased fertility challenges, boosting the demand for assisted reproductive technologies (ART) and other infertility treatments.
The continuous innovation and refinement of ART, such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT), have significantly improved success rates and expanded the scope of infertility treatments. These technological advancements attract individuals and couples seeking effective solutions.
Increased awareness about infertility, along with a reduction in the stigma associated with seeking infertility treatment, has led more people to explore fertility options. Educational campaigns, media coverage, and online resources have contributed to this growing awareness.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/1841
What Challenges Constrain the Infertility Treatment Market?
Infertility treatments, especially advanced procedures like IVF and genetic screening, can be expensive. The cost of multiple treatment cycles, medications, and additional services can become a significant financial burden for patients. Limited insurance coverage for infertility treatments in some regions further exacerbates this challenge.
While the success rates of infertility treatments have improved over the years, they are not guaranteed for every individual or couple. The unpredictability of treatment outcomes can be emotionally and mentally taxing for patients, leading to disappointment and increased financial strain.
Access to infertility treatments may be limited in certain geographic regions, particularly in low-resource areas or countries with restrictive healthcare systems. This lack of access can disproportionately affect individuals with limited financial means, reducing their chances of receiving necessary treatments.
Ethical dilemmas surrounding assisted reproductive technologies (ART), such as embryo selection, egg and sperm donation, and surrogacy, raise important moral and societal questions. Balancing reproductive autonomy with ethical considerations is an ongoing challenge in the field.
Unveiling Geographic Patterns in the Infertility Treatment Market
Currently, North America stands as a prominent player in the global Infertility Treatment market, with a significant share of the industry. This dominance can be attributed to the region's advanced medical facilities, well-established regulatory frameworks, and a higher level of healthcare awareness. The presence of renowned fertility clinics, access to cutting-edge assisted reproductive technologies (ART), and a culture of openness to fertility treatments contribute to North America's market leadership.
Within Europe, several countries emerge as major revenue generators in the Infertility Treatment market. The United Kingdom, Germany, and France are at the forefront of technological adoption and digital transformation initiatives, which extends to the field of reproductive healthcare. These nations prioritize healthcare innovation, research, and patient-centered care, fostering an environment conducive to the growth of the Infertility Treatment market.
The Asia Pacific region is poised for substantial growth in the Infertility Treatment market and is anticipated to outpace other regions during the forecast period. Rapidly developing economies, such as China and India, are witnessing a significant rise in demand for infertility treatments due to multiple factors, including urbanization, changing lifestyles, delayed parenthood, and increasing awareness about fertility options. Japan and Australia also contribute to the growth of the market in the Asia Pacific region.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/infertility-treatment-market
Segments Covered in Report
For the purpose of this report, Emergen Research has segmented the global infertility treatment market based on product, procedure, patient type, end-use and region:
- Product Outlook (Revenue, USD Billion; 2019-2030)
- Microscopes
- Media & Consumables
- Accessories
- Procedures Outlook (Revenue, USD Billion; 2019-2030)
- Assisted Reproductive Technology
- Artificial Insemination
- Fertility Surgeries
- Patient Type Outlook (Revenue, USD Billion; 2019-2030)
- Female Infertility Treatment
- Male Infertility Treatment
- End-use Outlook (Revenue, USD Billion; 2019-2030)
- Fertility Centers
- Hospitals & Surgical Clinics
- Cryobanks
- Other End-use
- Regional Outlook (Revenue, USD Billion; 2019–2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of Middle East & Africa
- North America
Closing Statement
The Infertility Treatment market is poised for remarkable growth, fueled by the rising demand for effective reproductive solutions, improved patient outcomes, and increased awareness regarding fertility issues. As couples and individuals seek advanced options to overcome infertility challenges, the integration of cutting-edge technology and evidence-based approaches is becoming essential. Leading fertility treatment providers, including established names like CCRM Fertility, IVIRMA Global, and CARE Fertility Group, are driving innovation and expanding their services, driving the market towards a projected value of USD 3.10 Billion by 2030, with a notable CAGR of 8.1%.
Curated Reports You Shouldn't Miss: Dive In Now!
NGS Sample Preparation Market By Workflow (NGS Library Preparation Kits, Semi-automated Library Preparation, Others), By Application (Oncology, Clinical Investigation, Others), and By End-User (Academic, Clinical, Others), Forecasts to 2027
Nucleic Acid Isolation and Purification Market, By Product (Kits and Reagents, Instruments), Isolation & purification type (DNA, RNA), By Application, By Method, By End User, and By Region Forecast to 2030
Viral Vector and Plasmid Manufacturing Market, By Vector Type (Plasmid DNA, AAV), By Disease Type (Cancer, Genetic Disorder), By Application (Gene Therapy, Cell Therapy), By End-Use, and By Region Forecast to 2030
Healthcare Interoperability Solutions Market, By Interoperability Level (Foundational Interoperability, Structural Interoperability, Semantic Interoperability), By Type (Software Solutions, Services), By End-use, and By Region Forecast to 2032
Global Non-Invasive Prenatal Testing Market By Method, By End-Use, By Application, By Region, Forecasts to 2017-2027
Orthopedics Devices Market By Product, By Type (Joint Reconstruction, Spinal, Trauma, Arthroscopy, Dental Implants, Orthobiologics), By Application (Hip, Knee, Spine, Cranio-Maxillofacial (CMF), Dental, Sports Medical, Extremities, and Trauma (SET)), Forecasts to 2027
Radiation Dose Management Market, By Product (Dosimeters, Area Process Monitors), By Component (Software, Service), By Application (Radiography, Angiography, Mammography), and By Region Forecast to 2030
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Explore Our Japanese Version: Infertility Treatment Market
Read our Press Release @ https://www.emergenresearch.com/press-release/global-infertility-treatment-market
